Company intelligence
Lonza
Making the Medicines of Tomorrow
About Lonza
Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.
Verified activity
Signals from Lonza
43 published signals
Presence & Recognition
Lonza Head of Immunology, Early Development Services Noel Smith participates in the panel discussion at BioCentury Grand Rounds Europe on 24 September 2026 on Llamas' Next Leaps in Small Biologics
Reported by Lonza
Presence & Recognition
Lonza colleague Régis Lelou, Director, Commercial Development Bioconjugates, will present a session titled Building the Future of Bioconjugate Supply at CPHI Milan on 7 October 2026.
Reported by Lonza
People
Lonza is hiring a Senior MES Recipe Designer in Stein, AG to shape the future of digital manufacturing.
Reported by Janine Clare
People
Lonza is hiring a senior QA expert for a GMP environment in Stein, AG.
Reported by Janine Clare
Presence & Recognition
Lonza featured Nina Hentzen, Head of Preclinical Development Bioconjugates, as she shares how the company helps customers navigate early-stage bioconjugate development with confidence.
Reported by Erin O'Brien Gilbert, Ph.D.
Research & Knowledge
Lonza published the structure of the protein rubredoxin at 0.43 Ångström resolution, showcasing the intricate molecular architecture.
Reported by Peng Wang, Ph.D.
Presence & Recognition
Lonza is attending BioProcess International 2026 in Boston, MA, USA on September 23, 2026, to discuss complex biologics and novel modalities.
Reported by Lonza
Research & Knowledge
Lonza bioconjugation experts Anette Sommer, Remon Van Geel, and Anthony DeBoer explored recent trends driving demand for targeted therapies and new approaches including dual-payload ADCs in an interview with Technology Networks.
Reported by Lonza
Presence & Recognition
Lonza is hosting a fireside chat on September 23, 2026, at Boston, MA, featuring Dr. Yvette Stallwood, Head of Early Development Services.
Reported by Dimor Elbers
People
Lonza is hiring a CQV Engineer for Bend, Oregon to support pharmaceutical equipment and processes.
Reported by Shraddha Deshmukh
Presence & Recognition
Lonza will be attending the 16th American Drug Delivery & Formulation Summit in Boston from September 14 to 15, 2026, to discuss formulation, drug delivery, and product development innovations.
Reported by Lonza
People
Lonza welcomed Ashlee Connors to the Portsmouth, New Hampshire Training Specialist II position specializing in Aseptic Processing.
Reported by Ashlee Connors
Research & Knowledge
Lonza published a research paper on mammalian genes combining to make previously uncharacterized proteins.
Reported by Bingnan Gu, PhD, MBA
Presence & Recognition
Lonza featured Nina Hentzen, Head of Preclinical Development Bioconjugates, as she shares how the company helps customers navigate early-stage bioconjugate development with confidence.
Reported by Dimor Elbers
People
Lonza is hiring an Associate Scientist - QC for a 12-month temporary contract in Visp, Switzerland, with English and German speaking requirements.
Reported by Vera Pankhania
People
Lonza is looking to hire a Equipment Engineer - Small Devices (CQV & Reliability) to take direct ownership of the core pharmaceutical equipment lifecycle in Visp, Switzerland.
Reported by Vera Pankhania
People
Lonza is hiring a Production Engineer - Small Devices for a 6-month full-time contingent role at BioAtrium in Visp, Switzerland.
Reported by Vera Pankhania
Presence & Recognition
Lonza is attending the IPAC-RS 2026 Nasal Innovation Forum in Jersey City, US, on September 16-17.
Reported by Lonza
Presence & Recognition
Lonza is hosting the BioUK lunchtime networking event Bioconjugates UK connect: Accelerating ADC innovation from ideas to IND at the Bee House in Milton Park, Oxford, UK on 17 September 2026
Reported by Lonza
People
Lonza closed a chapter after two years of professional and personal growth at the company.
Reported by Stavros Cholidis
Products & Services
Lonza launched Zayann Care, the first mobile phytotherapy application available on Google Play Store.
Reported by PEROUMALNAIK Jean-Marc
Presence & Recognition
Lonza is connecting with the pharma community at CPHI Milan 2026 to build stronger partnerships and unlock potential together.
Reported by Luka Ilic
Presence & Recognition
Lonza is participating in the BioUK lunchtime networking event on 17 September 2026 at Bee House, Milton Park, Oxford, UK
Reported by Laurentia Setiawan PhD MBA
People
Lonza is hiring an Associate Director for Quality Assurance to join the Quality team in Bend Oregon.
Reported by Shraddha Deshmukh